Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The Sierra Leone Trial to Introduce a Vaccine Against Ebola: An Evaluation of rVSV∆G-ZEBOV-GP Vaccine Tolerability and Safety During the West Africa Ebola Outbreak.

Literature DB >> 29788345

The Sierra Leone Trial to Introduce a Vaccine Against Ebola: An Evaluation of rVSV∆G-ZEBOV-GP Vaccine Tolerability and Safety During the West Africa Ebola Outbreak.

Mohamed Samai¹, Jane F Seward¹, Susan T Goldstein², Barbara E Mahon², Durodami Radcliffe Lisk¹, Marc-Alain Widdowson², Mohamed I Jalloh¹, Stephanie J Schrag², Ayesha Idriss¹, Rosalind J Carter², Peter Dawson³, S A S Kargbo¹, Bailah Leigh¹, Mohamed Bawoh¹, Jennifer Legardy-Williams², Gibrilla Deen¹, Wendy Carr², Amy Callis², Robert Lindblad³, James B W Russell¹, Carey R Petrie³, Augustin E Fombah¹, Brima Kargbo⁴, Wendi McDonald¹, Olamide D Jarrett¹, Robert E Walker⁵, Paul Gargiullo², Donald Bash-Taqi¹, Laura Gibson⁵, Abu Bakarr Fofanah⁴, Anne Schuchat².

Abstract

Clinical Trials Registration: ClinicalTrials.gov [NCT02378753] and Pan African Clinical Trials Registry [PACTR201502001037220].

Entities: Species

Mesh：

Substances：

Year: 2018 PMID： 29788345 PMCID： PMC5961340 DOI： 10.1093/infdis/jiy020

Source DB: PubMed Journal: J Infect Dis ISSN： 0022-1899 Impact factor: 5.226

26 in total

1. Ebola virus disease (EVD) in West Africa: an extraordinary epidemic.

Authors:
Journal: Wkly Epidemiol Rec Date: 2015-03-06

2. The Ebola epidemic: a global health emergency.

Authors: Lawrence O Gostin; Daniel Lucey; Alexandra Phelan
Journal: JAMA Date: 2014-09-17 Impact factor: 56.272

3. Six-Month Safety Data of Recombinant Vesicular Stomatitis Virus-Zaire Ebola Virus Envelope Glycoprotein Vaccine in a Phase 3 Double-Blind, Placebo-Controlled Randomized Study in Healthy Adults.

Authors: Scott A Halperin; Jose R Arribas; Richard Rupp; Charles P Andrews; Laurence Chu; Rituparna Das; Jakub K Simon; Matthew T Onorato; Kenneth Liu; Jason Martin; Frans A Helmond
Journal: J Infect Dis Date: 2017-06-15 Impact factor: 5.226

4. Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial.

Authors: Ana Maria Henao-Restrepo; Ira M Longini; Matthias Egger; Natalie E Dean; W John Edmunds; Anton Camacho; Miles W Carroll; Moussa Doumbia; Bertrand Draguez; Sophie Duraffour; Godwin Enwere; Rebecca Grais; Stephan Gunther; Stefanie Hossmann; Mandy Kader Kondé; Souleymane Kone; Eeva Kuisma; Myron M Levine; Sema Mandal; Gunnstein Norheim; Ximena Riveros; Aboubacar Soumah; Sven Trelle; Andrea S Vicari; Conall H Watson; Sakoba Kéïta; Marie Paule Kieny; John-Arne Røttingen
Journal: Lancet Date: 2015-08-03 Impact factor: 79.321

5. Trends in Risk of Pregnancy Loss Among US Women, 1990-2011.

Authors: Lauren M Rossen; Katherine A Ahrens; Amy M Branum
Journal: Paediatr Perinat Epidemiol Date: 2017-10-20 Impact factor: 3.980

6. Conducting clinical trials in outbreak settings: Points to consider.

Authors: H Clifford Lane; Hilary D Marston; Anthony S Fauci
Journal: Clin Trials Date: 2016-01-14 Impact factor: 2.486

7. Ring vaccination with rVSV-ZEBOV under expanded access in response to an outbreak of Ebola virus disease in Guinea, 2016: an operational and vaccine safety report.

Authors: Pierre-Stéphane Gsell; Anton Camacho; Adam J Kucharski; Conall H Watson; Aminata Bagayoko; Séverine Danmadji Nadlaou; Natalie E Dean; Abdourahamane Diallo; Abdourahmane Diallo; Djidonou A Honora; Moussa Doumbia; Godwin Enwere; Elizabeth S Higgs; Thomas Mauget; Diakite Mory; Ximena Riveros; Fofana Thierno Oumar; Mosoka Fallah; Alhassane Toure; Andrea S Vicari; Ira M Longini; W J Edmunds; Ana Maria Henao-Restrepo; Marie Paule Kieny; Sakoba Kéïta
Journal: Lancet Infect Dis Date: 2017-10-09 Impact factor: 25.071

8. Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!).

Authors: Ana Maria Henao-Restrepo; Anton Camacho; Ira M Longini; Conall H Watson; W John Edmunds; Matthias Egger; Miles W Carroll; Natalie E Dean; Ibrahima Diatta; Moussa Doumbia; Bertrand Draguez; Sophie Duraffour; Godwin Enwere; Rebecca Grais; Stephan Gunther; Pierre-Stéphane Gsell; Stefanie Hossmann; Sara Viksmoen Watle; Mandy Kader Kondé; Sakoba Kéïta; Souleymane Kone; Eewa Kuisma; Myron M Levine; Sema Mandal; Thomas Mauget; Gunnstein Norheim; Ximena Riveros; Aboubacar Soumah; Sven Trelle; Andrea S Vicari; John-Arne Røttingen; Marie-Paule Kieny
Journal: Lancet Date: 2016-12-23 Impact factor: 79.321

9. The ring vaccination trial: a novel cluster randomised controlled trial design to evaluate vaccine efficacy and effectiveness during outbreaks, with special reference to Ebola.

Authors:
Journal: BMJ Date: 2015-07-27

10. Safety and immunogenicity of rVSVΔG-ZEBOV-GP Ebola vaccine in adults and children in Lambaréné, Gabon: A phase I randomised trial.

Authors: Selidji T Agnandji; José F Fernandes; Emmanuel B Bache; Régis M Obiang Mba; Jessica S Brosnahan; Lumeka Kabwende; Paul Pitzinger; Pieter Staarink; Marguerite Massinga-Loembe; Verena Krähling; Nadine Biedenkopf; Sarah Katharina Fehling; Thomas Strecker; David J Clark; Henry M Staines; Jay W Hooper; Peter Silvera; Vasee Moorthy; Marie-Paule Kieny; Akim A Adegnika; Martin P Grobusch; Stephan Becker; Michael Ramharter; Benjamin Mordmüller; Bertrand Lell; Sanjeev Krishna; Peter G Kremsner
Journal: PLoS Med Date: 2017-10-06 Impact factor: 11.069

26 in total

1. Health Conditions in an Adult Population in Sierra Leone: Data Reported From the Sierra Leone Trial to Introduce a Vaccine Against Ebola (STRIVE).

Authors: Augustin E Fombah; Susan T Goldstein; Olamide D Jarrett; Mohamed I Jalloh; Jill El-Khorazaty; Durodami Radcliffe Lisk; Jennifer Legardy-Williams; Dudley A Pratt; Peter M George; James B W Russell; Stephanie J Schrag; Peter Dawson; Gibrilla F Deen; Wendy Carr; Robert Lindblad; Faustine James; Mohamed M Bah; John F Yillia; Jibao D Sandy; Patrick E Turay; Muhammad-Abbas Conteh; Laurence Slutsker; Barbara E Mahon; Mohamed Samai; Jane F Seward
Journal: J Infect Dis Date: 2018-05-18 Impact factor: 5.226

2. Operationalizing International Regulatory Standards in a Limited-Resource Setting During an Epidemic: The Sierra Leone Trial to Introduce a Vaccine Against Ebola (STRIVE) Experience.

Authors: Abdul Karim Kabineh; Wendy Carr; Mahnaz Motevalli; Jennifer Legardy-Williams; Willietta Vincent; Barbara E Mahon; Mohamed Samai
Journal: J Infect Dis Date: 2018-05-18 Impact factor: 5.226

3. Monitoring Serious Adverse Events in the Sierra Leone Trial to Introduce a Vaccine Against Ebola.

Authors: Olamide D Jarrett; Jane F Seward; Augustin E Fombah; Robert Lindblad; Mohamed I Jalloh; Jill El-Khorazaty; Peter Dawson; Deron Burton; Jane Zucker; Wendy Carr; Mohamed M Bah; Gibrilla F Deen; Peter M George; Faustine James; Durodami R Lisk; Dudley Pratt; James B W Russell; Jibao D Sandy; Patrick Turay; Mary J Hamel; Stephanie J Schrag; Robert E Walker; Mohamed Samai; Susan T Goldstein
Journal: J Infect Dis Date: 2018-05-18 Impact factor: 5.226

4. Clinical Surveillance and Evaluation of Suspected Ebola Cases in a Vaccine Trial During an Ebola Epidemic: The Sierra Leone Trial to Introduce a Vaccine Against Ebola.

Authors: Muhammad-Abbas Conteh; Susan T Goldstein; Haja R Wurie; Jane Gidudu; Durodami Radcliffe Lisk; Rosalind J Carter; Jane F Seward; Lee M Hampton; David Wang; Lauren E Andersen; Melissa Arvay; Stephanie J Schrag; Peter Dawson; Augustin E Fombah; Carey R Petrie; Daniel R Feikin; James B W Russell; Robert Lindblad; S A S Kargbo; Mohamed Samai; Barbara E Mahon
Journal: J Infect Dis Date: 2018-05-18 Impact factor: 5.226

5. Lessons Learned in Clinical Trial Communication During an Ebola Outbreak: The Implementation of STRIVE.

Authors: Amy Callis; Victoria M Carter; Aparna Ramakrishnan; Alison P Albert; Lansana Conteh; Alhaji Amadu Barrie; Lucian Fahnbulleh; Mark M Koroma; Samuel Saidu; Otis Williams; Mohamed Samai
Journal: J Infect Dis Date: 2018-05-18 Impact factor: 5.226

6. Will a Single-Cycle Adenovirus Vaccine Be Effective Against Ebola Virus?

Authors: Michael R Holbrook
Journal: J Infect Dis Date: 2018-11-05 Impact factor: 5.226

7. Perceptions and acceptability of an experimental Ebola vaccine among health care workers, frontline staff, and the general public during the 2014-2015 Ebola outbreak in Sierra Leone.

Authors: Mohamed F Jalloh; Mohammad B Jalloh; Alison Albert; Brent Wolff; Amy Callis; Aparna Ramakrishnan; Emily Cramer; Paul Sengeh; Samuel Abu Pratt; Lansana Conteh; Rana Hajjeh; Rebecca Bunnell; John T Redd; Anna Mia Ekström; Helena Nordenstedt
Journal: Vaccine Date: 2019-02-10 Impact factor: 3.641

8. Prevention of Ebola virus disease through vaccination: where we are in 2018.

Authors: Yves Lévy; Clifford Lane; Peter Piot; Abdul Habib Beavogui; Mark Kieh; Bailah Leigh; Seydou Doumbia; Eric D'Ortenzio; Claire Lévy-Marchal; Jerome Pierson; Deborah Watson-Jones; Vinh-Kim Nguyen; Heidi Larson; Julia Lysander; Christine Lacabaratz; Rodolphe Thiebaut; Augustin Augier; David Ishola; Stephen Kennedy; Geneviève Chêne; Brian Greenwood; James Neaton; Yazdan Yazdanpanah
Journal: Lancet Date: 2018-08-10 Impact factor: 79.321

9. Baseline Asymptomatic Malaria Infection and Immunogenicity of Recombinant Vesicular Stomatitis Virus-Zaire Ebola Virus Envelope Glycoprotein.

Authors: Barbara E Mahon; Jakub Simon; Marc-Alain Widdowson; Mohamed Samai; Eric Rogier; Jennifer Legardy-Williams; Kenneth Liu; Jarad Schiffer; James Lange; Carolynn DeByle; Robert Pinner; Anne Schuchat; Laurence Slutsker; Susan Goldstein
Journal: J Infect Dis Date: 2021-12-01 Impact factor: 5.226

Review 10. Ebola virus disease.

Authors: Shevin T Jacob; Ian Crozier; William A Fischer; Angela Hewlett; Colleen S Kraft; Marc-Antoine de La Vega; Moses J Soka; Victoria Wahl; Anthony Griffiths; Laura Bollinger; Jens H Kuhn
Journal: Nat Rev Dis Primers Date: 2020-02-20 Impact factor: 52.329